Allison W. Kurian

1 month ago | healio.com | Josh Friedman |Heather Biele |Allison W. Kurian |Ann H. Partridge

Key takeaways: Most women with breast cancer who paused endocrine therapy for pregnancy did not resume. These women had a higher rate of breast recurrence and death than expected. Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, according to results of a nearly 25-year retrospective study.

Sep 1, 2023 | jmg.bmj.com | Rachel Hodan |Kerry Kingham |Allison W. Kurian

Recurrent BRCA2 exon 3 deletion in Assyrian families Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Aug 10, 2023 | healio.com | Jennifer Byrne |Allison W. Kurian |Mindy Valcarcel

Source/Disclosures Disclosures: Kurian reports no relevant financial disclosures. We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.